Unit 1611: Pharmacogenomics and Personalized Medicine

1. Introduction to Pharmacogenomics

• Definition of pharmacogenomics
• Scope and significance in personalized medicine
• Genetic variations impacting drug response and metabolism
• Examples illustrating variability in drug efficacy and adverse effects

2. Principles of Pharmacogenetics

• Basic genetic concepts relevant to pharmacology (genes, alleles, polymorphisms)
• Impact of genetic variations on drug efficacy and safety
• Dosage considerations based on genetic differences
• Role in predicting and preventing adverse drug reactions

3. Drug Metabolism Pathways

• Overview of drug metabolism phases
  • Phase I reactions (oxidation, reduction, hydrolysis)
  • Phase II reactions (conjugation processes)
• Key enzymes (e.g., cytochrome P450 family)
• Genetic polymorphisms affecting metabolic enzymes
• Influence on individual drug response and toxicity

4. Pharmacogenomic Testing

• Overview of genotyping and sequencing techniques
  • PCR-based methods
  • Microarrays
  • Next-generation sequencing (NGS)
• Interpretation of pharmacogenomic test results
• Challenges in clinical integration
  • Cost, accessibility, and turnaround time
• Benefits to clinical decision-making

5. Clinical Applications of Pharmacogenomics

• Optimizing drug choice and dosing
• Case studies demonstrating improved outcomes
  • Warfarin dosing and CYP2C9/VKORC1 genotyping
  • Clopidogrel efficacy and CYP2C19
• Limitations and considerations in clinical practice

6. Regulatory and Ethical Considerations

• Regulatory frameworks governing pharmacogenomic tests
• Ethical issues:
  • Genetic privacy and data security
  • Informed consent processes
  • Patient autonomy and decision-making
• Guidelines by regulatory bodies (FDA, EMA)

7. Pharmacogenomics in Cancer Treatment

• Role of genetic biomarkers in targeted therapies
• Examples:
  • HER2 testing in breast cancer
  • EGFR mutations in lung cancer
• Benefits and challenges in oncology practice
• Impact on treatment selection and prognosis

8. Pharmacogenomics in Psychiatry

• Genetic testing to guide psychotropic medication selection
• Examples of genes implicated in psychiatric drug response
• Personalized approaches to dosing and medication choice
• Implications for treatment adherence and efficacy

9. Future Directions in Pharmacogenomics

• Emerging technologies (e.g., CRISPR, AI-driven analysis)
• Integration with big data and electronic health records
• Advances in precision medicine approaches
• Potential for broader clinical adoption and novel therapies
• Challenges and opportunities ahead